Published in Mol Biol Cell on January 19, 2005
Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta (2007) 4.74
Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions. J Proteome Res (2007) 1.48
Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS (2012) 1.44
Claudin family of proteins and cancer: an overview. J Oncol (2010) 1.42
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Regulation and roles for claudin-family tight junction proteins. IUBMB Life (2009) 1.26
A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol (2008) 1.09
Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin. Endocrinology (2006) 1.08
Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem (2008) 1.07
Wound healing revised: a novel reepithelialization mechanism revealed by in vitro and in silico models. J Cell Biol (2013) 1.05
Claudin and occludin expression and function in the seminiferous epithelium. Philos Trans R Soc Lond B Biol Sci (2010) 1.01
Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res (2008) 0.98
Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell (2013) 0.98
Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2008) 0.97
Cell migration. Compr Physiol (2012) 0.94
The polarized distribution of Na+,K+-ATPase: role of the interaction between {beta} subunits. Mol Biol Cell (2010) 0.90
Regulation of blood-testis barrier (BTB) dynamics during spermatogenesis via the "Yin" and "Yang" effects of mammalian target of rapamycin complex 1 (mTORC1) and mTORC2. Int Rev Cell Mol Biol (2013) 0.86
Disruption of occludin function in polarized epithelial cells activates the extrinsic pathway of apoptosis leading to cell extrusion without loss of transepithelial resistance. BMC Cell Biol (2009) 0.85
Polarity proteins as regulators of cell junction complexes: implications for breast cancer. Pharmacol Ther (2013) 0.84
Epithelial junctions and polarity: complexes and kinases. Curr Opin Nephrol Hypertens (2008) 0.82
Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers. J Membr Biol (2005) 0.82
Junctional proteins of the blood-brain barrier: New insights into function and dysfunction. Tissue Barriers (2016) 0.80
Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair. Gastroenterology (2016) 0.79
Trends in drug delivery through tissue barriers containing tight junctions. Tissue Barriers (2013) 0.78
Entamoeba histolytica contains an occludin-like protein that can alter colonic epithelial barrier function. PLoS One (2013) 0.76
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol (2001) 9.62
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol (1986) 8.74
Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol (1998) 7.78
The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem (1998) 5.34
Signalling to and from tight junctions. Nat Rev Mol Cell Biol (2003) 4.37
A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol (1997) 3.86
Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol (2002) 3.59
Polyproline II structure in a sequence of seven alanine residues. Proc Natl Acad Sci U S A (2002) 3.54
Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol (2003) 3.38
Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol (1997) 3.35
The Calpha ---H...O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc Natl Acad Sci U S A (2001) 2.97
Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci (2000) 2.97
Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J Cell Biol (1996) 2.94
Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. Mol Biol Cell (2003) 2.76
Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol (2004) 2.54
Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol (2000) 2.48
Occludin confers adhesiveness when expressed in fibroblasts. J Cell Sci (1997) 2.10
Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol (2001) 2.06
Role for actin filament turnover and a myosin II motor in cytoskeleton-driven disassembly of the epithelial apical junctional complex. Mol Biol Cell (2004) 2.05
A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol (2003) 1.88
Tight junctions and human diseases. Med Electron Microsc (2003) 1.87
Highly repetitive structure and its organization of the silk fibroin gene. J Mol Evol (1994) 1.62
Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci U S A (2003) 1.57
The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem (2000) 1.50
Tight junction, a platform for trafficking and signaling protein complexes. J Cell Biol (2000) 1.41
Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J Membr Biol (1999) 1.26
The role of PII conformations in the calculation of peptide fractional helix content. Protein Sci (1997) 1.23
Assessment of inflammatory events in epithelial permeability: a rapid screening method using fluorescein dextrans. Epithelial Cell Biol (1995) 1.22
Occludin modulates transepithelial migration of neutrophils. J Biol Chem (2000) 1.20
Occludin localization at the tight junction requires the second extracellular loop. J Membr Biol (2000) 1.17
Intestinal epithelia (T84) possess basolateral ligands for CD11b/CD18-mediated neutrophil adherence. Am J Physiol (1995) 1.10
Perturbation of the tight junction permeability barrier by occludin loop peptides activates beta-catenin/TCF/LEF-mediated transcription. EMBO Rep (2001) 1.03
Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol (2002) 0.96
Combinatorial approaches: a new tool to search for highly structured beta-hairpin peptides. Proc Natl Acad Sci U S A (2002) 0.95
Isolation and characterization of mouse high-glycine/tyrosine proteins. J Biol Chem (1997) 0.83
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest (2005) 3.15
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology (2002) 2.66
Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell (2005) 2.46
Intrachromosomal looping is required for activation of endogenous pluripotency genes during reprogramming. Cell Stem Cell (2013) 1.52
Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure. Gastroenterology (2005) 1.42
Formulation and delivery issues for monoclonal antibody therapeutics. Adv Drug Deliv Rev (2006) 1.40
Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152). J Med Chem (2012) 1.27
Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol (2008) 1.24
Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A3. J Immunol (2004) 1.18
Myosin II regulates the shape of three-dimensional intestinal epithelial cysts. J Cell Sci (2008) 1.16
The second loop of occludin is required for suppression of Raf1-induced tumor growth. Oncogene (2005) 1.10
A key claudin extracellular loop domain is critical for epithelial barrier integrity. Am J Pathol (2008) 1.09
Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors. Am J Physiol Gastrointest Liver Physiol (2006) 1.03
Multidrug resistance-associated transporter 2 regulates mucosal inflammation by facilitating the synthesis of hepoxilin A3. J Immunol (2008) 1.02
Analysis of the interaction with the hepatitis C virus mRNA reveals an alternative mode of RNA recognition by the human La protein. Nucleic Acids Res (2011) 1.02
A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase. Pharm Res (2005) 0.97
Structural and functional analysis of HtrA1 and its subdomains. Structure (2012) 0.96
Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro. Pharm Res (2008) 0.90
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor. J Biol Chem (2013) 0.90
Emerging technologies that overcome biological barriers for therapeutic protein delivery. Expert Opin Biol Ther (2003) 0.90
The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding. Biochemistry (2008) 0.87
Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification. Am J Physiol Gastrointest Liver Physiol (2004) 0.85
Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights. Biochem J (2010) 0.84
Solution model of the intrinsically disordered polyglutamine tract-binding protein-1. Biophys J (2012) 0.84
Calcium-independent inhibition of PCSK9 by affinity-improved variants of the LDL receptor EGF(A) domain. J Mol Biol (2012) 0.83
Identification of an iron-hepcidin complex. Biochem J (2008) 0.82
Spectroscopic studies on nicotine and nornicotine in the UV region. Chirality (2013) 0.82
Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv Drug Deliv Rev (2005) 0.82
Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis. Eur J Pharm Biopharm (2011) 0.80
Oral peptide delivery: prioritizing the leading technologies. Ther Deliv (2011) 0.80
Ridge-tile-like chiral topology: synthesis, resolution, and complete chiroptical characterization of enantiomers of edge-sharing binuclear square planar complexes of Ni(II) bearing achiral ligands. J Am Chem Soc (2010) 0.80
The multi-mode polarization modulation spectrometer: part 1: simultaneous detection of absorption, turbidity, and optical activity. Anal Biochem (2004) 0.79
Structure and stability insights into tumour suppressor p53 evolutionary related proteins. PLoS One (2013) 0.78
Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells. Infect Immun (2005) 0.77
Observation of a single-stranded DNA/pyrrolobenzodiazepine adduct. J Am Chem Soc (2011) 0.77
Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins. Int J Biochem Cell Biol (2008) 0.77
Analysis methods of polysorbate 20: A new method to assess the stability of polysorbate 20 and established methods that may overlook degraded polysorbate 20. Pharm Res (2002) 0.77
Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use. Eur J Pharm Biopharm (2013) 0.76
The oxido-reductase enzyme glutathione peroxidase 4 (GPX4) governs Salmonella Typhimurium-induced neutrophil transepithelial migration. Cell Microbiol (2014) 0.75
Erratum: Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature (2016) 0.75
Telepathology at the Armed Forces Institute of Pathology: A Retrospective Review of Consultations From 1996 to 1997. Arch Pathol Lab Med (2017) 0.75
Strong and weak zinc binding sites in human zinc-α2-glycoprotein. FEBS Lett (2013) 0.75
A strategy to improve selectivity and targeting to epithelial-derived cancer cells. J Control Release (2012) 0.75
Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection. J Drug Target (2010) 0.75
DePEGylation studies: PEG-RBC stability in conditions consistent with massive transfusion. Clin Lab Sci (2011) 0.75